Posted Wed, Dec, 07,2011
Libertas is proud to announce that Drug Target Insights has been included in the 2012 Australian Research Council’s Excellence in Research for Australia (ERA) List.
The ERA list assesses the quality of research to be used in universities across Australia. This year’s list has over 22,000 recommended journals for use within Australia’s top universities and takes around 2 years to compile.
Only the top Australian universities are eligible to submit their published data to the ERA initiative. Having Drug Target Insights included in the ERA list shows its popularity with Australian researchers and the high quality of papers published in Drug Target Insights.
Also included in the ERA 2012 List were:
Analytical Chemistry Insights
Biomarker Insights
Cancer Informatics
Evolutionary Bioinformatics
Environmental Health Insights
Gene Regulation and Systems Biology
Integrative Medicine Insights
Substance Abuse: Research and Treatment
Visit the Drug Target Insights homepage and view the Editor in Chief’s call for papers
Posted in: Open Access
News Categories
Thu 08 Oct, 2015
Published This Week (5th - 9th October)Thu 08 Oct, 2015
Biomarker Insights Paper Endorsed by Editor in ChiefWed 07 Oct, 2015
Interview with Professor Jamie DaviesI found the submission management system for Evolutionary Bioinformatics to be one of the most user-friendly around. The peer review was very rigorous and constructive. Support staff were polite and furnished accurate information almost instantly. I strongly recommend other scientists to consider this journal.
Facebook Google+ Twitter
Pinterest Tumblr YouTube